COVISTIX

COVISTIX maintains its ability to detect the Omicron Variant, in addition to detecting SARS-CoV-2 and all of its major…
Read More...

SAN DIEGO and MEXICO CITY, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”)…
Read More...

Sorrento has received orders from its logistics partner and a large diagnostic laboratory client for official…
Read More...

SAN DIEGO and MEXICO CITY, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”)…
Read More...

SAN DIEGO and MEXICO CITY, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”)…
Read More...

COVISTIX has received CE mark and marketing authorization from FAMHP (Federal Agency for Medicines and Health Products)…
Read More...

As a general screening for all-comers (i.e. COVID-19 symptomatic and asymptomatic populations), COVISTIX (n=783) has an…
Read More...

Sorrento received official EUA registration and product import license: COFEPRIS EUA registration number “OFICIO:…
Read More...